Table 6 Reporting of control vs. experimental interventions
Trial characteristic | Control (N = 105) | Experimental (N = 119) | Total (N = 224) | |||
|---|---|---|---|---|---|---|
>2 components reported | (%) | >2 components reported | (%) | >2 components reported | (%) | |
Test type: | ||||||
 Biochemical | 3 | (30) | 10 | (40) | 13 | (37) |
 Biopsy | 0 | (−) | 1 | (50) | 1 | (33) |
 Clinical | 2 | (11) | 6 | (43) | 8 | (25) |
 Electrophysiology | 2 | (29) | 1 | (10) | 3 | (18) |
 Imaging (all) | 6 | (17) | 17 | (34) | 23 | (27) |
   Endoscopy | 2 | (14) | 5 | (45) | 7 | (28) |
   Radiology | 4 | (19) | 12 | (31) | 16 | (27) |
 No test | 12 | (86) | 4 | (100) | 16 | (89) |
 Standard Care | 1 | (10) | 0 | (−) | 1 | (10) |
 Telemedicine | 0 | (−) | 0 | (−) | 0 | (−) |
 Multiple | 2 | (25) | 2 | (17) | 4 | (20) |
Care sector: | ||||||
 Emergency | 3 | (25) | 5 | (42) | 8 | (33) |
 Primary | 4 | (36) | 10 | (56) | 14 | (48) |
 Secondary | 9 | (20) | 12 | (24) | 21 | (22) |
 Tertiary | 12 | (43) | 13 | (43) | 25 | (43) |
 Multiple | 0 | (−) | 1 | (13) | 1 | (6) |
Total | 28 | (27) | 41 | (34) | 69 | (31) |